# Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.

> **NCT03078907** · PHASE4 · COMPLETED · sponsor: **Actelion** · enrollment: 108 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Selexipag
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03078907
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-08
- **Primary completion:** 2020-02-10
- **Final completion:** 2020-02-10
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03078907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03078907, "Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03078907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*